Hassani, E., Mozzendizaji, S., Shafiei-Irannejad, V., & Mohammadzadeh, A. (2025). Metformin boosts doxorubicin efficacy and increases CD8 + T cell frequency in mouse breast cancer. Clinical and Translational Oncology, 27(5), 2060-2066. https://doi.org/10.1007/s12094-024-03764-2
Chicago Style (17th ed.) CitationHassani, Elaheh, Sahand Mozzendizaji, Vahid Shafiei-Irannejad, and Adel Mohammadzadeh. "Metformin Boosts Doxorubicin Efficacy and Increases CD8 + T Cell Frequency in Mouse Breast Cancer." Clinical and Translational Oncology 27, no. 5 (2025): 2060-2066. https://doi.org/10.1007/s12094-024-03764-2.
MLA (9th ed.) CitationHassani, Elaheh, et al. "Metformin Boosts Doxorubicin Efficacy and Increases CD8 + T Cell Frequency in Mouse Breast Cancer." Clinical and Translational Oncology, vol. 27, no. 5, 2025, pp. 2060-2066, https://doi.org/10.1007/s12094-024-03764-2.